Please ensure Javascript is enabled for purposes of website accessibility

pharmaceutical acquisitions

Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake
Feb 9, 2026

Lilly bets on next-generation cell therapy with $2.4B deal for Orna

Eli Lilly agreed to buy Orna Therapeutics for up to $2.4 billion, gaining in vivo CAR-T and circular RNA technology platform.

Pfizer to buy Metsera in $5B obesity drug deal
Sep 22, 2025

Pfizer to buy Metsera in $5B obesity drug deal

Pfizer will acquire Metsera for nearly $5B, boosting its push into obesity treatments with potential oral and injectable drugs.

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.